Sorted By:

Relevance


Medicare Monday: What is the Extra Help program?

PhRMA  |  Blog Post

Learn more about this program, also known as the low-income subsidy or LIS, in our short video:     For more information on the Extra Help program, check out our resources here.
http://catalyst.phrma.org/medicare-monday-what-is-the-extra-help-program

Special Edition Fact Check Friday: Why disclosing negotiated discounts and rebates won’t help patients

PhRMA  |  Blog Post

In fact, agreements between payers and hospitals and hospitals and suppliers are also not publicly disclosed – and for good reason.
http://catalyst.phrma.org/special-edition-fact-check-friday-why-disclosing-negotiated-discounts-and-rebates-wont-help-patients

Local Impact: State-by-State Medicaid Spending on Prescription Medicines

PhRMA  |  Fact Sheet

In fact, Medicaid programs spent on average just 4.5 percent on prescriptions drugs in 2015.
https://www.phrma.org/fact-sheet/local-impact-state-by-state-medicaid-spending-on-prescription-medicines

Why Medicaid-Style Rebates Aren’t Good for Part D Beneficiaries or the Program

PhRMA  |  Fact Sheet

We’re taking a closer look at proposals that could hurt the success of Medicare Part D. One such proposal is to apply mandatory Medicaid-style rebates to Medicare Part D. What these proposals fail to acknowledge are the substantial rebates that already exist in the Medicare Part D program...
https://www.phrma.org/fact-sheet/why-medicaid-style-rebates-aren-t-good-for-part-d-beneficiaries-or-the-program

Creating Medicines Also Creates Jobs: Sheet Metal Workers Explain

From Hope To Cures  |  From Our Network

...
http://www.fromhopetocures.org/video/creating-medicines-also-creates-jobs-sheet-metal-workers-explain

4 Facts on Why Drug Importation is Bad for Patients

PhRMA  |  Fact Sheet

Counterfeit drug trafficking is a multibillion dollar business that threatens the health and well-being of patients. The World Health Organization estimates 10 percent of medicines worldwide are counterfeit, including up to half of the drugs consumed in developing nations. Fortunately for America...
https://www.phrma.org/fact-sheet/4-facts-on-why-drug-importation-is-bad-for-patients

Access to Rheumatoid Arthritis Medicines in Exchange Plans (2016)

PhRMA  |  Fact Sheet

This analysis provides insights into how plans in the health insurance exchanges and employer plans cover Rheumatoid Arthritis medicines. Findings are primarily based on an analysis of silver plans available in all states nationwide in 2016....
https://www.phrma.org/fact-sheet/access-to-rheumatoid-arthritis-medicines-in-exchange-plans-2016

North Dakota's 2016 Exchange Plans

PhRMA  |  Fact Sheet

Potential Size of Exchange Market: About 79,000 North Dakota residents State oversight can help ensure that health insurance exchange coverage offers the access to needed medicines the Affordable Care Act promised. States can continue to protect patients in their state ...
https://www.phrma.org/fact-sheet/north-dakota-s-2016-exchange-plans

Access to Hyperlipidemia Medicines in Exchange Plans (2016)

PhRMA  |  Fact Sheet

This analysis provides insights into how plans in the health insurance exchanges and employer plans cover hyperlipidemia medicines. Findings are primarily based on an analysis of silver plans available in all states nationwide in 2016....
https://www.phrma.org/fact-sheet/access-to-hyperlipidemia-medicines-in-exchange-plans-2016

NAFTA tribunal fails to rule on Canada’s patent utility doctrine

PhRMA  |  Blog Post

Through a quick legislative fix, Canadian courts would be required to live up to global standards of patentability, which purposely set a low bar for demonstrating utility. 
http://catalyst.phrma.org/nafta-tribunal-fails-to-rule-on-canadas-patent-utility-doctrine

Access to Multiple Sclerosis Medicines in Exchange Plans (2016)

PhRMA  |  Fact Sheet

This analysis provides insights into how plans in the health insurance exchanges and employer plans cover M.S. medicines. Findings are primarily based on an analysis of silver plans available in all states nationwide in 2016....
https://www.phrma.org/fact-sheet/access-to-multiple-sclerosis-medicines-in-exchange-plans-2016

Fact Check Friday: The Truth About Negotiation in Medicare Part D

PhRMA  |  Blog Post

Check back for more Fact Check Fridays or learn more about Medicare in our Medicare Monday series.
http://catalyst.phrma.org/fact-check-friday-the-truth-about-negotiation-in-medicare-part-d

Resource Library

PhRMA  |  From PhRMA

Explore PhRMA’s Resource Library and discover videos, fact sheets, graphics and reports on a wide range of issues, topics and diseases. 
https://www.phrma.org/resources/resource-library

Who Has a Seat at ICER's Table?

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/who-has-a-seat-at-icer-s-table

Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines

PhRMA  |  Blog Post

A recent analysis by Xcenda looked at the Veterans Affairs (VA) program, a program that relies on a set formulary, to see how it compares to coverage offered by Part D and found that Part D plans covered an average of 81 percent of 25 new first-in-class therapies, compared to just 12 percent covered by the VA.
http://catalyst.phrma.org/medicare-monday-same-bad-ideas-continue-to-threaten-part-d-and-beneficiary-access-to-medicines

Four Facts on Why Drug Importation is Bad for Patients

PhRMA  |  Fact Sheet

Due to the U.S. Food and Drug Administration’s (FDA) comprehensive drug approval process, medicines on the U.S. market are widely regarded as the safest in the world. The U.S.’s relatively closed distribution system plays a critical role in helping to keep the global proliferation of counterfeit ...
https://www.phrma.org/fact-sheet/four-facts-on-why-drug-importation-is-bad-for-patients

Access to Cystic Fibrosis Medicines in Exchange Plans (2016)

PhRMA  |  Fact Sheet

This analysis provides insights into how plans in the health insurance exchanges and employer plans cover cystic fibrosis medicines. Findings are primarily based on an analysis of silver plans available in all states nationwide in 2016....
https://www.phrma.org/fact-sheet/access-to-cystic-fibrosis-medicines-in-exchange-plans-2016

Big Profits Seen In Rare Diseases

From Hope To Cures  |  From Our Network

The global pharmaceutical industry is pouring billions of dollars into developing treatments for rare diseases, which once drew little interest from major drugmakers but now point the way toward a new era of innovative therapies and big profits. The invest...
http://www.fromhopetocures.org/big-profits-seen-in-rare-diseases

ICYMI – NYT: Unable to Meet the Deductible or the Doctor

PhRMA  |  Blog Post

You Still May Pay A Steep Price For Prescriptions.
http://catalyst.phrma.org/icymi-nyt-unable-to-meet-the-deductible-or-the-doctor

Medicare Monday: A Short Video on Medicare Part D

PhRMA  |  Blog Post

Medicare Part D provides nearly 40 million older Americans and people living with disabilities with affordable access to prescription drug coverage. There’s a lot of information out there on the Part D program and its success. To help people better understand how the program helps save mon...
http://catalyst.phrma.org/medicare-monday-short-video-medicare-part-d

Unable to Meet the Deductible or the Doctor

Access Better Coverage  |  From Our Network

But for other services and items, like prescription drugs, marketplace customers often have to meet their deductible before insurance starts to help.
http://www.accessbettercoverage.org/social-news/unable-to-meet-the-deductible-or-the-doctor

Access to HIV/AIDS Medicines in Exchange Plans (2016)

PhRMA  |  Fact Sheet

This analysis provides insights into how plans in the health insurance exchanges and employer plans cover HIV/AIDS medicines. Findings are primarily based on an analysis of silver plans available in all states nationwide in 2016....
https://www.phrma.org/fact-sheet/access-to-hiv/aids-medicines-in-exchange-plans-2016

ICYMI: The Wall Street Journal Makes the Case for Sharing Truthful, Non-Misleading Information

PhRMA  |  Blog Post

On Friday, The Wall Street Journal editorialized on free speech in the context of sharing scientific and medical information, something critical for the U.S.
http://catalyst.phrma.org/icymi-the-wall-street-journal-makes-the-case-for-sharing-truthful-non-misleading-information

Drugmaker And University Ally To Seek Cure For AIDS

From Hope To Cures  |  From Our Network

“I can’t see something popping up that is going to be broadly successful in the next five to 10 years.
http://www.fromhopetocures.org/drugmaker-and-university-ally-to-seek-cure-for-aids

She Has Health Insurance, But Can't Pay Her Medical Bills. She's Not Alone.

Access Better Coverage  |  From Our Network

Instead, she says, she's now overwhelmed with medical bills.
http://www.accessbettercoverage.org/social-news/she-has-health-insurance-but-cant-pay-her-medical-bills

You have reviewed the first 150 results out of 1198. Each page contains 25 results. You're on page 6.

prev 1 2 3 4 5 6 next